indazoles has been researched along with Lymphoma, Mantle-Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chinen, Y; Horiike, S; Kobayashi, T; Kuroda, J; Kuwahara-Ota, S; Maegawa, S; Matsumura-Kimoto, Y; Mizuno, Y; Shimura, Y; Takimoto, T; Tanba, K; Taniwaki, M; Tsukamoto, T | 1 |
| Andorsky, DJ; Assouline, S; Forero-Torres, A; Jones, V; Klein, LM; Kolibaba, KS; Patel-Donnelly, D; Sharman, JP; Shi, W; Smith, M; Yasenchak, CA; Ye, W | 1 |
| Andreeff, M; Jin, L; Kimura, S; Konopleva, M; Miida, T; Raffeld, M; Shikami, M; Tabe, Y | 1 |
1 trial(s) available for indazoles and Lymphoma, Mantle-Cell
| Article | Year |
|---|---|
An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Indazoles; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Proteins; Pyrazines; Syk Kinase; Waldenstrom Macroglobulinemia | 2019 |
2 other study(ies) available for indazoles and Lymphoma, Mantle-Cell
| Article | Year |
|---|---|
Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Aniline Compounds; Cell Line, Tumor; Humans; Indazoles; Lymphoma, Mantle-Cell; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Sulfonamides | 2018 |
Class IA PI3K inhibition inhibits cell growth and proliferation in mantle cell lymphoma.
Topics: Cell Cycle; Cell Proliferation; Chromones; Humans; Indazoles; Lymphoma, Mantle-Cell; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidinones; Sulfonamides | 2014 |